Pulmonary arterial hypertension (PAH) is a disorder characterized by elevated pressure in the blood vessels of the lungs. If left untreated, pulmonary hypertension can lead to heart failure. A comprehensive evaluation is required for every patient suspected of having pulmonary hypertension to verify the diagnosis and rule out other similar conditions. More information about pulmonary hypertension can be found at the Pulmonary Hypertension Association website.
Dr. John Dallas and Dr. Anna Dvorak have expertise in the evaluation and management of patients with pulmonary hypertension. Patients with pulmonary hypertension are seen at the Seton Heart Specialty Care and Transplant Center as part of a multidisciplinary team including cardiologists, pulmonologists, nurse practicioners, social workers, pharmacists, and dieticians.
PCCCA offers a full range of treatments for pulmonary hypertension including oral therapies, infusion therapies (both subcutaneous and intravenous) and inhaled therapies.